UK patients should understand that: Available evidence is largely from Phase 2 studies with relatively short follow-up periods Long-term cardiovascular outcome data are not yet available for either agent Phase 3 trials are ongoing, and results will inform future regulatory submissions to the MHRA UK patients interested in accessing these treatments through clinical trials may wish to consult the NIHR 'Be Part of Research' portal (bepartofresearch.nihr.ac.uk) or ClinicalTrials.gov for current recruitment opportunities
Tanaka C, Coling DE, Manohar S, Chen GD, Hu BH, Salvi R, Henderson D
Why Choose Yoo Direct Health for Gut Health
She also practices in Newport Beach, California
While the peptide is not a weight-loss therapy, improving gut health may support metabolic function and indirectly influence weight regulation
they're about unleashing a vibrant, energetic version of yourself